Literature DB >> 8878277

Effect of allowing for ethnic group in prenatal screening for Down's syndrome.

H C Watt1, N J Wald, D Smith, A Kennard, J Densem.   

Abstract

We conducted a study to investigate ethnic group differences in levels of serum markers used in screening for Down's syndrome [serum alpha-fetoprotein (AFP), unconjugated oestriol (uE3), total human chorionic gonadotrophin (hCG), free alpha- and free beta-hCG, and dimeric inhibin-A], to estimate the extent to which maternal weight differences between ethnic groups explain these differences, and to estimate the effect of adjusting for ethnic group and maternal weight on screening performance. Serum measurements were taken from women who were screened prenatally for Down's syndrome. AFP, uE3, and hCG concentrations were available from 9462 white, 4215 black, and 4392 South Asian women with singleton pregnancies without Down's syndrome or neural tube defects between 15 and 22 weeks' gestational age. Frozen serum samples were available from a subset of 922 white, 449 black, and 135 South Asian women and were used for measurement of free alpha-hCG, free beta-hCG, and inhibin. Values were expressed as multiples of the median (MOM) for women of the same gestational age. There were statistically significant differences in the serum marker levels between ethnic groups that were not explained by differences in maternal weight. The main differences were found in black women compared with white women; black women had serum AFP levels 22 per cent higher (95 per cent confidence interval 20-24 per cent), total hCG levels 19 per cent higher (16-22 per cent), and free beta-hCG levels 12 per cent (3-21 per cent) higher. The other differences were less than 10 per cent. Adjusting for ethnic group only had a small estimated effect on screening performance: a maximum of about 0.5 per cent extra detection at a 5 per cent false-positive rate. At a fixed risk cut-off level, the false-positive rate will not be materially different between different ethnic groups. Adjusting serum markers for ethnic groups improves Down's syndrome screening performance to a very small extent. It is worthwhile because of its established value in AFP screening for open neural tube defects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878277     DOI: 10.1002/(SICI)1097-0223(199608)16:8<691::AID-PD946>3.0.CO;2-2

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  12 in total

Review 1.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 2.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 3.  Second trimester serum tests for Down's Syndrome screening.

Authors:  S Kate Alldred; Jonathan J Deeks; Boliang Guo; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

4.  Korean-specific parameter models for calculating the risk of Down syndrome in the second trimester of pregnancy.

Authors:  Ji Young Kwon; In Yang Park; Yong Gue Park; Young Lee; Guisera Lee; Jong Chul Shin
Journal:  J Korean Med Sci       Date:  2011-11-29       Impact factor: 2.153

5.  Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study.

Authors:  Tim I M Korevaar; Eric A P Steegers; Yolanda B de Rijke; Sarah Schalekamp-Timmermans; W Edward Visser; Albert Hofman; Vincent W V Jaddoe; Henning Tiemeier; Theo J Visser; Marco Medici; Robin P Peeters
Journal:  Eur J Epidemiol       Date:  2015-05-12       Impact factor: 8.082

6.  Maternal serum median levels of alpha-foetoprotein, human chorionic gonadotropin & unconjugated estriol in second trimester in pregnant women from north-west India.

Authors:  Gurjit Kaur; Jyoti Srivastav; Suresh Sharma; Anju Huria; Poonam Goel; Bir Singh Chavan
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

7.  Fetal Down syndrome screening models for developing countries; Part I: Performance of Maternal Serum Screening.

Authors:  Chanane Wanapirak; Wirawit Piyamongkol; Supatra Sirichotiyakul; Fuanglada Tongprasert; Kasemsri Srisupundit; Suchaya Luewan; Kuntharee Traisrisilp; Phudit Jatavan; Theera Tongsong
Journal:  BMC Health Serv Res       Date:  2019-11-27       Impact factor: 2.655

8.  The distribution of fetal nuchal translucency thickness in normal Korean fetuses.

Authors:  Jin-Hoon Chung; Jae-Hyug Yang; Mi-Jin Song; Jeong-Yeon Cho; Young-Ho Lee; So-Yeon Park; Myoung-Jin Moon; Ha-Jung Lim; June-Seek Choi; Joo-Oh Kim; Joong-Sik Shin; Hyun-Kyong Ahn; Jung-Yul Han; Moon-Young Kim; Kyu-Hong Choi; Hyun-Mee Ryu
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

Review 9.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

Review 10.  Urine tests for Down's syndrome screening.

Authors:  S Kate Alldred; Boliang Guo; Yemisi Takwoingi; Mary Pennant; Susanna Wisniewski; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.